| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 138,906 | 123,864 | | Cost of Revenue | 75,857 | 72,196 | | | Gross Profit | 63,049 | 51,668 | | | Operating Expenses | | Research Development | 28,604 | 24,986 | | Selling General and Administrative | 43,018 | 31,528 | | Non Recurring | (34,332) |
-
| | Others | 1,919 | 1,151 | | | | Total Operating Expenses | 39,209 |
-
| | | | Operating Income or Loss | 23,839 | (5,996) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 751 | 870 | | Earnings Before Interest And Taxes | 24,591 | (5,126) | | Interest Expense | 248 | 2,956 | | Income Before Tax | 24,343 | (8,081) | | Income Tax Expense | 5,130 | 1,665 | | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | 19,213 | (9,746) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 19,213 | (9,746) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | $19,213 | ($9,746) |
|
0.10% Nasdaq 
0.27%
Income Statement
